TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Race Oncology Ltd. ( (AU:RAC) ) has provided an announcement.
Race Oncology Ltd announced the quotation of 1,295,909 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 9, 2025. This move is part of the company’s strategy to enhance its capital structure and potentially improve its market position, offering stakeholders an opportunity to engage with its growth trajectory.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, primarily focused on developing and commercializing cancer therapies. The company is known for its innovative approaches to oncology treatment and aims to address unmet medical needs in the cancer treatment market.
Average Trading Volume: 369,828
Technical Sentiment Signal: Buy
Current Market Cap: A$684.8M
Learn more about RAC stock on TipRanks’ Stock Analysis page.